GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population

Parkinsonism and Related Disorders

Volumn 16, Issue 7, 2010, Pages 447-452

  Kiyohara, C ^a   Miyake, Y ^b   Koyanagi, M ^b   Fujimoto, T ^b   Shirasawa, S ^b   Tanaka, K ^b   Fukushima, W ^c   Sasaki, S ^d   Tsuboi, Y ^b   Yamada, T ^b   Oeda, T ^e   Miki, T ^c   Kawamura, N ^a   Sakae, N ^a   Fukuyama, H ^f   Hirota, Y ^c   Nagai, M ^g  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UTANO NATIONAL HOSPITAL   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Case control study; Genetic polymorphism; Glutathione S transferase; Interaction; Japanese population; Parkinson's disease

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE O1; GLUTATHIONE TRANSFERASE O2; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PESTICIDE; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PARKINSON DISEASE; PESTICIDE SPRAYING; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; JAPAN; MIDDLE AGED; POPULATION GROUP; PSYCHOLOGY; RETROSPECTIVE STUDY; RISK; SMOKING;

AGED; ENVIRONMENTAL EXPOSURE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; PESTICIDES; POLYMORPHISM, GENETIC; POPULATION GROUPS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 77954957576     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.04.009     Document Type: Article

References (30)

1. Warner T.T., Schapira A.H. Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 2003, 53(Suppl. 3):S16-S23. discussion S-5.
2. Tsang A.H., Chung K.K. Oxidative and nitrosative stress in Parkinson's disease. Biochim Biophys Acta 2009, 1792:643-650.
3. Szabo C., Ischiropoulos H., Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007, 6:662-680.
4. Reynolds M.R., Berry R.W., Binder L.I. Nitration in neurodegeneration: deciphering the " Hows" " nYs" Biochemistry 2007, 46:7325-7336.
5. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995, 30:445-600.
6. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005, 45:51-88.
7. Di Ilio C., Sacchetta P., Iannarelli V., Aceto A. Binding of pesticides to alpha, mu and pi class glutathione transferase. Toxicol Lett 1995, 76:173-177.
8. Kiyohara C., Yamamura K.I., Nakanishi Y., Takayama K., Hara N. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to Lung cancer in a Japanese population. Asian Pac J Cancer Prev 2000, 1:293-298.
9. Priyadarshi A., Khuder S.A., Schaub E.A., Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 2000, 21:435-440.
10. Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007, 64:990-997.
11. Yuille M., Condie A., Hudson C., Kote-Jarai Z., Stone E., Eeles R., et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 2002, 99:4216-4218.
12. Tanaka-Kagawa T., Jinno H., Hasegawa T., Makino Y., Seko Y., Hanioka N., et al. Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun 2003, 301:516-520.
13. Miyake Y., Sasaki S., Tanaka K., Fukushima W., Kiyohara C., Tsuboi Y., et al. Dietary fat intake and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci 2010, 288:117-122.
14. Andersson T., Alfredsson L., Kallberg H., Zdravkovic S., Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005, 20:575-579.
15. Perez-Pastene C., Graumann R., Diaz-Grez F., Miranda M., Venegas P., Godoy O.T., et al. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett 2007, 418:181-185.
16. De Palma G., Mozzoni P., Mutti A., Calzetti S., Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 1998, 352:1986-1987.
17. Stroombergen M.C., Waring R.H. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 1999, 18:141-145.
18. Singh M., Khan A.J., Shah P.P., Shukla R., Khanna V.K., Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 2008, 312:131-138.
19. Ahmadi A., Fredrikson M., Jerregard H., Akerback A., Fall P.A., Rannug A., et al. GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset. Biochem Biophys Res Commun 2000, 269:676-680.
20. Bandmann O., Vaughan J., Holmans P., Marsden C.D., Wood N.W. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997, 350:1136-1139.
21. Tison F., Coutelle C., Henry P., Cassaigne A. Glutathion S-transferase (class mu) phenotype in Parkinson's disease. Mov Disord 1994, 9:117-118.
22. Harada S., Fujii C., Hayashi A., Ohkoshi N. An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 2001, 288:887-892.
23. Kelada S.N., Stapleton P.L., Farin F.M., Bammler T.K., Eaton D.L., Smith-Weller T., et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett 2003, 337:5-8.
24. Menegon A., Board P.G., Blackburn A.C., Mellick G.D., Le Couteur D.G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998, 352:1344-1346.
25. Wahner A.D., Glatt C.E., Bronstein J.M., Ritz B. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett 2007, 413:274-278.
26. Nishimura M., Kuno S., Kaji R., Yasuno K., Kawakami H. Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease. Mov Disord 2005, 20:901-902.
27. Whitbread A.K., Mellick G.D., Silburn P.A., Le Couteur D.G., Board P.G. Glutathione transferase omega class polymorphisms in Parkinson disease. Neurology 2004, 62:1910-1911.
28. Morens D.M., Grandinetti A., Reed D., White L.R., Ross G.W. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?. Neurology 1995, 45:1041-1051.
29. Castagnoli K., Murugesan T. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?. Neurotoxicology 2004, 25:279-291.
30. Deng Y., Newman B., Dunne M.P., Silburn P.A., Mellick G.D. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease. Neurosci Lett 2004, 366:326-331.